Editor's key points † This study presents very interesting results of goal-directed therapy in patients undergoing colorectal surgery. † The patients, aerobically fit or not, were randomized to receive goal-directed fluid therapy (GDT) vs standard fluid management therapy during surgery. † GDT patients tended to have an increased length of stay and time to fitness for discharge. † Contrary to the expectation, this study showed no advantage of GDT.
Perioperative fluid management for patients undergoing elective major surgery is controversial. 1 Surgery alters fluid balance, 2 generates a systemic inflammatory response which increases oxygen consumption, and is associated with an increase in cardiac output and oxygen delivery. An inability to meet the metabolic demands of recovery from surgery is associated with increased morbidity and mortality. 3 Defining and attaining an adequate circulating volume is complex, and the fluid deficit before surgery varies among individuals. 4 Recommended fluid administration strategies during major colorectal surgery include volume restriction 5 6 and maintenance of an adequate circulating volume while avoiding fluid and salt overload. 7 Goal-directed fluid therapy (GDT) aimed at optimizing cardiac output and oxygen delivery has been shown to improve outcome for high-risk surgical patients. 8 9 Intraoperative colloid GDT guided by oesophageal Doppler monitoring (ODM) has been associated with significant reductions in the time to readiness for discharge (RfD) and rate of complications in elective intra-abdominal 10 and colorectal surgery. 11 12 Individualized GDT through stroke volume (SV) optimization has recently been recommended by the UK National Institute for Health and Clinical Excellence (NICE) as a standard of care during major surgery. 13 Of note, the NICE simplified the recommended GDT algorithm, placing more emphasis on SV maximization.
14 Cardiopulmonary Exercise Testing (CPET) is a non-invasive measure of cardiorespiratory function. It has a clear ability to quantify cardiorespiratory reserve in the non-surgical setting. Previous studies have suggested that it is capable of identifying patients with poor aerobic fitness who may be less able to maintain perioperative oxygen delivery and are at increased risk of mortality and clinically important complications after surgery. 15 -17 We set out to validate the simplified GDT algorithm in patients undergoing elective colorectal surgery, hypothesizing that intraoperative GDT might reduce the time to RfD and complication rates as in previous studies. We further planned to investigate whether this would remain true in patients with good aerobic fitness.
Methods
This double-blind stratified randomized controlled trial (RCT) was approved by the Cornwall 16 and within these strata were allocated to the intervention, GDT or standard fluid management (control) groups by random block allocation using sequentially numbered opaque sealed envelopes (Fig. 1 ).
Perioperative management and masking
A comprehensive description of standard perioperative care and of the blinding procedure can be found in the Supplementary Appendix. Perioperative surgical care was conducted in line with enhanced recovery principles. The majority of patients came to an admission ward on the day of surgery. Bowel preparation was discouraged; those patients receiving bowel preparation were admitted for an i.v. infusion of 1-2 litre of Hartmann's solution in the 12 h preceding their arrival in the operating theatre, according to our previously reported protocol. 18 Local consensus guidelines for perioperative anaesthetic care for bowel surgery were readily available. All participants received general anaesthesia; for pragmatic reasons, the conduct of this was left to the discretion of the consultant anaesthetist. Local guidelines suggest supplementary thoracic epidural anaesthesia for open procedures and intrathecal morphine with local anaesthetic or local anaesthetic field blocks for laparoscopic operations. Intraoperative crystalloid, colloid, blood products, and inotropes/vasopressors were administered by the anaesthetist based on estimated maintenance fluid requirements, intraoperative losses, and the measurement of standard haemodynamic variablesaiming for a maintenance rate of 10 (Fig. 2 ). Group allocation, ODM readings, and algorithm-guided colloid administration were concealed from other staff in the operating theatre by screens.
The investigator had no involvement in perioperative decision-making or postoperative care.
Postoperative care
Standardized postoperative care was provided on a dedicated colorectal surgery ward. Admission to the critical care unit was at the discretion of the surgeon or anaesthetist. All patients were allowed free fluids, light diet, or both on the evening of surgery if tolerated. There was no formal protocol for postoperative fluid administration though local guidelines suggest a daily fluid intake of 2 litre. Early mobilization was encouraged, epidurals were discontinued at 48-72 h, and pain managed with oral analgesics at the earliest opportunity.
Postoperative outcomes were recorded by a researcher blinded to group allocation. The primary outcome measure was surgical RfD based on predefined criteria, that is, tolerance of oral diet, mobilization and self-support at an appropriate level, adequate pain control with simple oral analgesics, return of adequate lower gastrointestinal function, and adequate stoma care, where applicable.
Secondary outcomes included actual length of stay (LOS), critical care admission, 30 and 90 day mortality, and 30 day hospital readmission rates. Postoperative complications were categorized and graded on a five-point scale according to validated predefined criteria (Appendix 1). 19 
Safety monitoring
An independent safety committee reviewed all outcome data in a planned interim analysis which was not revealed to the research team. Adverse events were monitored by the local Research and Development service. Serious adverse events were additionally reported to the Ethical Committee.
Statistical analysis
Previous studies in elective colorectal surgery have demonstrated a reduction in time to RfD of 1.5 11 and 3 days. 12 Our existing median LOS of 9 days indicated that a sample of 148 patients would be sufficient to detect a 2 day reduction in the time to RfD at a significance level of 0.05 and a power of 0.9. We planned to compare the primary outcome within a subgroup of fit patients. At a significance level of 0.05 and 
Results
Two hundred and ninety-two patients were screened during the study period ( Fig. 1) . One hundred and seventy-nine participants were randomized: 89 to GDT and 90 to standard fluid management (control). One hundred and twenty-three were risk-stratified as aerobically fit and 56 as unfit.
All randomized patients completed the study. Four had their ODM data revealed to the anaesthetist in the operating theatre. Three patients (one fit and one unfit GDT patient, and one unfit control patient) were unblinded after intraoperative haemorrhage. One fit patient in the GDT group became haemodynamically unstable without apparent haemorrhage and the anaesthetist requested access to the ODM readings. No participants were lost to follow-up. All results were analysed on an intention-to-treat basis.
Overall, the patient characteristics and risk indices of the control and GDT groups were well matched ( Table 1, Supplementary Table S1 ). There were imbalances between the groups with respect to operative details: more rectal and open procedures were performed in the GDT group and this was associated with a greater use of epidural anaesthesia. Approximately one-third of the patients in each group had bowel preparation. GDT patients received more preoperative i.v. fluid replacement after bowel preparation.
Within the 'fit' and 'unfit' risk categories, the control and GDT treatment groups were well matched in terms of patient characteristics and risk indices (Table 2; Supplementary Table  S2 and S3) . Unfit patients were older with a greater proportion of resections being performed for carcinoma.
Intraoperative data and fluid administration
There were no significant differences between the control and GDT groups in heart rate, arterial pressure, or ODM readings immediately after induction of anaesthesia (Table 3) . Hartmann's solution. A mean intraoperative positive fluid balance of 3500 ml was evident in the control group. Patients in the GDT group received an average of 1360 ml of additional colloid from the investigator as per protocol (range 400-2200 ml). GDT patients had statistically significantly more intraoperative blood loss and urine output than control and were more likely to receive a transfusion of packed cells in the operating theatre (Table 1) . Four GDT patients (three fit and one unfit) and two control patients (both unfit) experienced significant intraoperative haemorrhage (brisk bleeding estimated at more than 3 litre).
Cardiac index (CI) increased throughout the operation in both groups, more so in the GDT patients. At skin closure, patients in the GDT group had significantly greater SV, corrected flow time (FTc), and CI than controls ( Table 3 ). The intraoperative increase in SV among GDT patients was greater in the fit than in the unfit (Supplementary Table S4 ).
The mean measured fluid balance for both GDT and control groups was very similar for both the operative day and the first full postoperative day (Tables 1 and 2 ).
Patient outcomes
Patient outcomes are summarized in Tables 4 and 5 and Supplementary Tables S5 and S6 . The overall median time to RfD was 5.8 days [inter-quartile range (IQR) 3.8-8.9], median LOS was 7.9 days (IQR 5.0-12.1), and 30 day mortality was 2.2%. Median times to RfD and LOS were around 2 days longer in GDT than in control patients; however, these differences were not statistically significant (6.8 vs 4.9 days; P¼0.09, and 8.8 vs 6.7 days; P¼0.09, respectively). There were no significant differences between the groups in other outcome measures (Table 4; Supplementary Table S6) . Fit patients in the GDT group had a significantly increased median time to RfD (7.0 vs 4.7 days; P¼0.01) and prolonged LOS (8.8 vs 6.0 days; P¼0.01) ( Table 5 ). Critical care admission was more common in the GDT group including three unplanned admissions after intraoperative haemorrhage. There were no significant differences in other outcome measures. There were two 30 day mortalities in the control group: one patient suffered an anastomotic leak requiring re-operation and died from multiorgan failure and one patient died from pneumonia. One patient in the GDT group died from pneumonia.
For unfit patients, time to RfD and LOS were similar between GDT and control groups (Supplementary Table S5 ). Unfit patients were more likely to be admitted to critical care than fit patients (22 of 56 vs 19 of 123, P,0.001). One postoperative death occurred within 30 days in the GDT group; this was from multiorgan failure after re-operation for anastomotic leak.
Discussion
Our intention was to evaluate whether supplementary colloid boluses guided by haemodynamic information provided by the ODM would enhance clinical outcomes in elective colorectal procedures. In contrast to previous studies, GDT did not improve RfD or LOS compared with standard care. Additionally in an aerobically 'fit' subgroup of patients, the GDT regimen was associated with detrimental effects on the primary outcome measures of RfD and LOS. We studied the impact of SV maximization on clinical outcomes and whether patients' aerobic fitness had a bearing. The extent to which we could explore this latter aim was limited by practical considerations. Post hoc power calculation suggests that a trial would have to recruit 160 aerobically unfit participants to detect a 2 day difference in time to RfD in such patients.
The trial was not powered to compare outcomes between aerobically fit and unfit groups, nor were the clinical or research teams blinded to the CPET results. Hence, our discussion focuses primarily on why our overall findings are at odds with previous studies and on the surprising results for the fit subgroup.
This was a pragmatic study conducted in an unselected population of patients having major surgery in a single unit. Heterogeneity of clinical personnel may have impacted on study findings, although in this sense our study was 'real world'. Perioperative care broadly adhered to the principles of enhanced recovery 20 but was not strictly protocolized and it is clear that intraoperative fluid therapy practice varied widely between attending anaesthetists.
Limitations of outcome measures
Our short overall median LOS compares favourably with UK national averages 21 but might attenuate differences attributable to any single intervention such as GDT. Length of hospital stay is a relatively subjective marker of outcome, affected by systematic failures, patient motivation, and socioeconomic status. 22 Our primary outcome measure, RfD by defined criteria, was designed to identify when participants were medically fit to go home. This was adjudicated by a blinded investigator in conjunction with surgical and nursing staff and was a median of 2 days earlier than actual discharge. Subjective elements such as deciding when a patient is ready to cope at home vary between surgeons; these blur the outcome measure and effectively reduce study power. Moreover, we used a previously validated scale (Appendix 1) 19 which failed to discriminate well between serious and relatively minor complications. For example, the intestinal ileus is graded the same whether it is treated with pro-kinetic drugs or with total parenteral nutrition on the basis that both of these represent 'pharmacological treatment'. Importantly, the scale fails to convey the duration of adverse events and we were thus unable to determine whether a prolonged time to discharge readiness may have been due to persistent complications.
Putting this study into context
There is considerable evidence that individualized goaldirected therapy in the perioperative period improves outcome for high-risk surgical patients. 9 23 Recent meta-analyses suggest that intraoperative ODM-guided haemodynamic management is associated with reduced LOS and complications in patients having major abdominal surgery. 24 25 Our contrasting findings imply that control perioperative care or our delivery of GDT was fundamentally different from that of those studies. The 'ideal' intraoperative i.v. fluid regimen for major bowel surgery has previously been expressed conceptually as a 'J'-shaped curve, 1 26 and previous studies with favourable results have suggested that the ODM enables the clinician to identify and maintain the optimal SV throughout surgery. 10 -12 Interestingly, the cardiac index of control patients in our study rose progressively throughout surgery which has not been the case in previous colorectal GDT trials. 11 12 This suggests to us that 'standard' pre-and intraoperative fluid management was different from these earlier studies, having perhaps been influenced by them. It is striking that at the conclusion of the procedure, our control group had Doppler readings very similar to those of the intervention groups in other trials (Supplementary Table S7 ). 11 12 Might 'standard care' in our institution be sufficiently good to neutralize the effects of GDT? The incidence of occult hypovolaemia during elective bowel surgery is affected by the duration of preoperative starvation, the use of bowel preparation, the magnitude of the physiological surgical stress response, and the degree of vasoparesis and venodilatation associated with neuraxial blockade. In the Enhanced Recovery era, advances in perioperative care may have attenuated these factors.
Set against this background, the average intraoperative fluid load (17 ml kg 21 h 21 ) given to each patient by the attending anaesthetists represents a substantial increase on previous trials. However, RfD and LOS for our control group compare favourably (Supplementary Table S7 ). In contrast to previous trials, 10 12 augmentation of SV by the investigator added nothing, and in fit patients, it appeared to be detrimental. This may be partially attributable to the manufacturers' simplification of the GDT algorithm. Previous versions have incorporated additional parameters-typically, an increase in corrected flow time, FTc, 10 12 or an increase in central venous pressure 11 as a signal that the circulating blood volume is replete. Colloid boluses are then withheld even after an increase in SV. Under the new algorithm, each individual is titrated close to the top of their Starling curve. In our view, this is SV 'maximization' rather than optimization and the approach has not yet been validated in an intraoperative setting. A recent trial comparing ODM-guided GDT to standard fluid therapy during laparoscopic colonic resection reported a longer time to discharge in patients receiving starch boluses according to an algorithm similar to ours. 27 SV manipulation solely by fluid treatment may be an overly simplistic approach to the replenishment of intraoperative tissue oxygen debt. Several trials have shown benefit when individualized, targeted oxygen delivery algorithms incorporating both fluid resuscitation and vasoactive drugs are applied to high-risk surgical patients, 9 23 28-30 although interestingly a recent study has suggested that a fixed-dose dopexamine regimen confers no additional benefit over colloid GDT for all comers having elective colorectal surgery. 31 Finally, it is important to appreciate how trial methodology differs from real-world practice. In our study, every GDT patient received at least an initial 200 ml colloid bolus regardless of FTc; and the investigator was committed to complete each bolus once started, regardless of the contemporaneous actions of the attending anaesthetist.
There is a strong possibility that aerobically fit GDT patients received inappropriate additional fluids with end-operative SVs which were considerably higher than those of the intervention group in previous trials. This trend was less apparent in unfit individuals. Potentially, the fit individuals with relatively compliant vasculature continued to increase their SVs in response to fluid and were given excess. Three fit GDT group patients vs no fit controls experienced significant intraoperative haemorrhage which appeared to be due to coincidental surgical mishap, but the possibility that the fluid load distended pelvic capacitance vessels cannot be disregarded.
It is not clear what the mechanism for the prolonged stay of GDT vs control in fit patients may have been. We did not see a higher rate of measured postoperative complications in the GDT group.
An important consideration is whether harm could be attributed to the specific colloid used by the investigator for boluses. Typically, trials of GDT during colorectal surgery have used gelatin solutions, 11 12 whereas we used 6% starch (Voluven). Starch solutions have been linked with coagulopathy and renal medullary damage, 32 -34 though such associations in patients with sepsis may not be applicable to the elective perioperative setting. There are a number of small studies implying that modern starches have an improved safety profile but the clinical usefulness of the solutions remains controversial. 34 In our study, there was increased average blood loss in GDT patients compared with controls, but we did not see more cases of acute renal impairment in the first postoperative week in that group (Table 4) . No GDT patients received more than the maximum recommended daily dose of 6% starch (50 ml kg 21 ) and there was no relationship between the volume of starch administered and the magnitude of postoperative creatinine increase or renal complications. Small trials are vulnerable to type I error. Patients having colonic surgery have a shorter RfD than those undergoing rectal surgery [in our trial, median 4.8 days (IQR 3.0-7.3) vs 7.0 days (IQR 4.0 -9.9), respectively (P,0.001 MW test), which is in line with national findings]. 21 Disproportions of colonic vs rectal and open vs laparoscopic procedures between groups may be important. In this RCT, more GDT than control patients had rectal resections, which would be expected to increase RfD. In contrast, previous studies of GDT in colorectal surgery had an imbalance in the opposite direction with proportionately more colonic surgery in the GDT group. 11 12 Aerobic fitness and LOS Previous GDT trials have not characterized the functional capacity of the participants. For this study, we used an AT threshold of 11 ml O 2 kg 21 min 21 to risk stratify patients as 'fit' or 'unfit'. 15 17 Functional capacity characterized in this way may have a bearing on RfD and LOS. Interestingly, on post hoc analysis, aerobically unfit patients having major rectal procedures tended to have a longer RfD and LOS than their fit counterparts but this association was lost in colonic surgery (fit vs unfit: 4.8 vs 4.5 and 6.0 vs 5.6 days, respectively). This is hypothesis-generating: the physiological stress of surgery may be lower in colonic than in rectal operations, such that the ability to increase oxygen delivery may be less important as a determinant of LOS in such patients. However, our study was not powered to address this.
Implications
GDT focusing on SV maximization may have important limitations including a risk of iatrogenic fluid overload which may be associated with prolonged hospital stay. Further studies are required to investigate whether alternative GDT algorithms may be of benefit. Recent NICE guidelines are in favour of intraoperative GDT during major surgery, but it is unclear whether the apparent benefits apply to all subgroups of patients. Future studies should seek to define the 'high-risk surgical patient' taking into account the planned surgical procedure (rectal vs colonic; open vs laparoscopic) and functional capacity, and evaluate the effects of GDT within these strata.
Supplementary material
Supplementary material is available at British Journal of Anaesthesia online.
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